About Agic capital
Agic Capital: A Leading European-Asian Private Equity Firm
Agic Capital is a private equity firm that specializes in industrial and medical technology investments in Europe. The company was founded in 2015 by Henry Cai, a seasoned investor with over two decades of experience in private equity and investment banking.
With offices in Frankfurt, Hong Kong, and Beijing, Agic Capital has established itself as a leading player in the European-Asian private equity market. The company's investment philosophy is based on identifying high-growth potential companies that can benefit from its extensive network of industry experts and strategic partners.
Agic Capital's Investment Strategy
Agic Capital invests primarily in mid-sized companies with strong growth potential across various sectors such as healthcare, advanced manufacturing, automation, and digitalization. The company's investment strategy is focused on acquiring controlling stakes or significant minority positions to actively support portfolio companies' growth plans.
The firm's team of experienced professionals works closely with portfolio companies to identify opportunities for operational improvement and value creation. Agic Capital leverages its extensive network of industry experts to provide strategic guidance to portfolio companies on matters such as product development, marketing strategy, supply chain optimization, and talent acquisition.
Agic Capital also seeks to create synergies between its portfolio companies by facilitating collaboration among them where possible. This approach enables the firm to unlock additional value for its investors while supporting the growth ambitions of its portfolio companies.
Recent Investments by Agic Capital
In recent years, Agic Capital has made several notable investments across Europe's industrial and medical technology sectors. Some of these include:
1) Acquisition of RENA Technologies GmbH: In 2020, Agic acquired a majority stake in RENA Technologies GmbH (RENA), a leading provider of wet chemical surface treatment solutions for semiconductor manufacturing. With this acquisition, Agic aims to support RENA's expansion into new markets while leveraging its expertise to enhance the company's product offerings further.
2) Investment in Sylentis SA: In 2019, Agic invested €20 million ($22 million) into Sylentis SA (Sylentis), a Spanish biotech company specializing in ophthalmology research. The investment will enable Sylentis to accelerate clinical trials for its lead drug candidate aimed at treating dry eye syndrome while expanding into other therapeutic areas.
3) Acquisition of Schlemmer Group: In 2018, Agic acquired Schlemmer Group (Schlemmer), a German-based manufacturer specializing in cable protection systems for automotive applications. With this acquisition valued at €190 million ($212 million), Agic aims to support Schlemmer's global expansion plans while leveraging the company's expertise to enhance product innovation further.
Conclusion
In conclusion; AGIC capital is an excellent choice if you are looking for an experienced partner who can help you grow your business through active management strategies tailored specifically towards your needs! Their team consists only out highly skilled professionals who have years upon years worth experience within their respective fields - making them one-of-a-kind when it comes down finding someone trustworthy enough handle all aspects related investing money wisely!